相关实验视频

Updated: Jan 14, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

选择性班级转换的监管为草发病提供了长期的治疗效益

Naoki Morita¹, Kohta Yamamoto², Ryutaro Tamano¹

¹Laboratory of Immunology and Infection Control, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, Japan.

|October 21, 2025

概括

免疫球蛋白A (IgA) 防止花粉入侵,降低了花粉热的易感性. 布里奥斯塔丁1是一种新型调节剂,通过调节B细胞反应,增强IgA的产生并减轻过敏症状.

科学领域:

免疫学免疫学免疫学
过敏研究研究过敏
分子生物学分子生物学

背景情况:

免疫球蛋白A (IgA) 在粘膜免疫中的作用已确立,但其在花粉热等过敏性疾病中的具体参与仍然不清楚.
现有研究尚未完全阐明IgA影响过敏性鼻炎的发展和进展的机制.

研究的目的:

为了研究IgA对花粉引起的花粉热的保护作用.
在B细胞中识别和描述IgA和免疫球蛋白E (IgE) 类切换的新型调节剂.
评估已识别的调节剂在缓解花粉热症状方面的治疗潜力.

主要方法:

使用IgA缺乏的小鼠来评估易受香柏花粉引起的花粉热的敏感性.
研究了布里奥斯塔丁1对B细胞类交换的影响,重点关注IgA和IgE的产生.
分析了参与布里奥斯坦丁1中介调节的信号通路,包括蛋白激酶C三角酶 (PKCδ),MEK,ERK,RUNX1,STAT5和ID2.
在小鼠肺组织中评估了Th2细胞因子的产生和乙素透.
在布里奥斯塔丁鼻内注射后,体内评估花粉热症状的缓解 1.

主要成果:

缺少IgA的小鼠对香柏花粉引起的花粉热的敏感性增加,证实了IgA在防止粘膜花粉入侵方面的作用.
布里奥斯塔丁1被确定为一种调节剂,通过PKCδ/MEK/ERK/RUNX1通路增强IgA的产生,并通过PKCδ/STAT5/ID2通路抑制IgE.
布里奥斯1治疗降低了Th2细胞因子水平和埃索诺菲尔在肺部的透.
布里奥斯塔丁1的鼻内注射导致小鼠降低了花粉热症状,效应在注射后长达3个月后观察到.

结论:

免疫球蛋白A在防止花粉入侵和缓解花粉热方面发挥着至关重要的作用.
布里奥斯塔丁1有效调节B细胞IgA/IgE类切换,为过敏性疾病提供潜在的治疗策略.
这些发现强调布里奥斯塔丁1是通过针对性调节免疫反应来缓解花粉热的有希望的药物.

关键词:

适应性免疫是一种适应性免疫.过敏过敏是一种过敏.免疫球蛋白是一种免疫球蛋白.免疫学免疫学免疫学炎症炎症是一种炎症.

更多相关视频

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

相关概念视频

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Dose-Response Relationship: Selectivity and Specificity

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...

Allergic Reactions

Allergic Reactions

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...